Latest & greatest articles for osteoarthritis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on osteoarthritis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on osteoarthritis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for osteoarthritis

581. Guidance on the use of cyclo-oxygenase (Cox) II selective inhibitors, celecoxib, rofecoxib, meloxicam and etodolac for osteoarthritis and rheumatoid arthritis

consideration of their risks and benefits, especially in patients who may be at increased risk of such adverse events. 1.3 Cox II selective inhibitors are not recommended for routine use in patients with rheumatoid arthritis (RA) or osteoarthritis (OA). They should be used, in preference to standard NSAIDs, when clearly indicated as part of the management of RA or OA only in patients who may be at high risk of developing serious gastrointestinal adverse effects. 1.4 Patients at high risk of developing (...) Guidance on the use of cyclo-oxygenase (Cox) II selective inhibitors, celecoxib, rofecoxib, meloxicam and etodolac for osteoarthritis and rheumatoid arthritis Guidance on the use of cyclo-oxygenase (Cox) II selective inhibitors, celecoxib, rofecoxib, meloxicam and etodolac for osteoarthritis and rheumatoid arthritis Guidance on the use of cyclo-oxygenase (Cox) II selective inhibitors, celecoxib, rofecoxib, meloxicam and etodolac for osteoarthritis and rheumatoid arthritis National Institute

2001 Health Technology Assessment (HTA) Database.

582. Homeopathic remedies for the treatment of osteoarthritis: a systematic review

, BIOSIS Previews and the Cochrane Library. The search terms were: 'osteoarthritis', 'osteoarthrosis', 'degenerative joint disease', 'degenerative arthritis', 'degenerative arthrosis', 'gonarthrosis' and 'coxarthrosis'. The full text terms 'homeop*' and 'homoeop*' and the MeSH terms 'homeopathy' and 'alternative medicine' were also used. Additional published and unpublished material was identified by examining the bibliographies of located studies, reviews and the authors' own files, and by contacting (...) Homeopathic remedies for the treatment of osteoarthritis: a systematic review Homeopathic remedies for the treatment of osteoarthritis: a systematic review Homeopathic remedies for the treatment of osteoarthritis: a systematic review Long L, Ernst E Authors' objectives To locate and assess all randomised controlled trials (RCTs) of homeopathy in the treatment of patients with osteoarthritis (OA). Searching The databases searched from their inception to August 2000 included MEDLINE, EMBASE, AMED

2001 DARE.

583. Herbal medicines for the treatment of osteoarthritis: a systematic review

Previews, CINAHL and the Cochrane Library were searched from their inception to May 2000. The search terms used were 'osteoarthritis', 'osteoarthrosis', 'degenerative joint disease', 'degenerative arthritis', 'degenerative arthrosis', 'gonarthrosis', 'coxarthrosis', 'botanic', 'phyto', 'herb', and all derivatives, together with individual plant and herb names. The bibliographies of the retrieved studies and reviews, and the authors' own files were also examined. Experts and manufacturers were contacted (...) Herbal medicines for the treatment of osteoarthritis: a systematic review Herbal medicines for the treatment of osteoarthritis: a systematic review Herbal medicines for the treatment of osteoarthritis: a systematic review Long L, Soeken K, Ernst E Authors' objectives To systematically review all randomised controlled trials (RCTs) on the effectiveness of herbal medicines and plant extracts, which are either taken orally or applied topically, for osteoarthritis. Searching MEDLINE, EMBASE, BIOSIS

2001 DARE.

584. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. (Abstract)

is unknown.To determine whether celecoxib, a COX-2-specific inhibitor, is associated with a lower incidence of significant upper GI toxic effects and other adverse effects compared with conventional NSAIDs.The Celecoxib Long-term Arthritis Safety Study (CLASS), a double-blind, randomized controlled trial conducted from September 1998 to March 2000.Three hundred eighty-six clinical sites in the United States and Canada.A total of 8059 patients (>/=18 years old) with osteoarthritis (OA) or rheumatoid (...) Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. Conventional nonsteroidal anti-inflammatory drugs (NSAIDs) are associated with a spectrum of toxic effects, notably gastrointestinal (GI) effects, because of inhibition of cyclooxygenase (COX)-1. Whether COX-2-specific inhibitors are associated with fewer clinical GI toxic effects

2000 JAMA Controlled trial quality: predicted high

585. Transcutaneous electrical nerve stimulation for knee osteoarthritis. Full Text available with Trip Pro

Transcutaneous electrical nerve stimulation for knee osteoarthritis. Osteoarthritis (OA) is a disease that affects synovial joints, which mainly causes degeneration and destruction of hyaline cartilage. To date, no curative treatment for OA exists. The primary goals for OA therapy are to relieve pain, maintain or improve functional status, and minimize deformity. Transcutaneous electrical nerve stimulation (TENS) is a noninvasive modality in physiotherapy that is commonly used to control both (...) acute and chronic pain arising from several conditions. A number of trials evaluating the efficacy of TENS in OA have been published.To assess the effectiveness of TENS in the treatment of knee OA. The primary outcomes of interest were those described by the Outcome Measures in Rheumatology Clinical Trials (OMERACT) 3, which included pain relief, functional status, patient global assessment, and change in joint imaging for studies of one year or longer. The secondary objective was to determine

2000 Cochrane

586. Balneotherapy for rheumatoid arthritis and osteoarthritis. (Abstract)

: June, 1999Studies were eligible if they were randomized controlled trials (RCT) comparing balneotherapy with any intervention or with no intervention. Patients included had rheumatoid arthritis (RA), osteoarthritis (OA) or some other form of arthritis. Trials incorporating patients with definite or classical rheumatoid arthritis (RA) as defined by the American Rheumatism Association Criteria (ARA) (Ropes 1958) (these criteria have changed over time) or by the criteria of Steinbrocker (1949) were (...) Balneotherapy for rheumatoid arthritis and osteoarthritis. Balneotherapy (hydrotherapy or spa therapy) for patients with arthritis is one of the oldest forms of therapy. One of the aims of balneotherapy is to soothe the pain and as a consequence to relieve patients' suffering and make them feel well.To perform a systematic review to assess the effects of balneotherapy for rheumatoid arthritis and osteoarthritis.Using the Cochrane search strategy, studies were found by screening: 1) The Medline

2000 Cochrane

587. Non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the knee. (Abstract)

Non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the knee. To determine whether there is a difference in the relative efficacy of individual non-steroidal anti-inflammatory drugs (NSAIDs) when used in the management of osteoarthritis (OA) of the knee.We searched Medline (1966-1995) and Bids Embase (Jan-Dec, 1980-1995). The searches were limited to publications in the English language, and were last perfomed in November 1996. We used modified Cochrane Collaboration search (...) strategy to identify all randomised controlled trials. The MeSH heading osteoarthritis was combined with the generic names of the 17 non-aspirin NSAIDs licensed in the UK for the management of OA in general practice. The search of Embase used the term "osteoarthritis" if present in the abstract, title or keywords, and was combined with the generic names of the 17 non-aspirin NSAIDs, only if they were mentioned in the title, abstract or keywords.All double blind, randomised controlled trials

2000 Cochrane

588. Analgesia and non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the hip. (Abstract)

Analgesia and non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the hip. To review all randomized trials of analgesics and anti-inflammatory therapy in osteoarthritis (OA) of the hip. To determine which non-steroidal, anti-inflammatory drug (NSAID) is the most effective, and which NSAID is the most toxic.We searched the Cochrane Musculoskeletal Group's trials register, the Cochrane Controlled Trials Register and Medline up to August 1994. Reference lists of all trials (...) were also manually searched.All randomized controlled trials comparing non-steroidal anti-inflammatory drugs (NSAIDs) and/or analgesics in patients with Osteoarthritis. The trials selected for inclusion were identified by one reviewer (TT) and rechecked by a second (MH).Qualitative assessments were performed using a quality scoring system designed for NSAID trials in rheumatoid arthritis. Both the design and analysis aspects of the trials were evaluated, each aspect being rated on a scale of 0 to 8

2000 Cochrane

589. Is exercise effective treatment for osteoarthritis of the knee?

Is exercise effective treatment for osteoarthritis of the knee? Is exercise effective treatment for osteoarthritis of the knee? Is exercise effective treatment for osteoarthritis of the knee? Petrella R J Authors' objectives To review and determine the effectiveness of exercise treatment for osteoarthritis of the knee. Searching The author searched MEDLINE from June 1966 to January 2000 using the following MeSH terms and textwords: 'osteoarthritis' or 'arthritis' and 'knee', 'exercise (...) , motor function or motor development. The treatments could be performed actively, passively or against resistance. Additional interventions were allowed. Studies were excluded if they concerned peri-operative exercise treatment, or if the intervention groups received identical exercise treatment and, therefore, no contrast existed between the intervention groups. Participants included in the review Patients with osteoarthritis of the knee, assessed using either clinical or radiological criteria

2000 DARE.

590. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis

) symptoms using meta-analysis combined with systematic quality assessment of clinical trials of these preparations in knee and/or hip OA. Searching MEDLINE (1966 to June 1999) and the Cochrane Controlled Trials Register were searched using the following as both MeSH terms and textwords: 'osteoarthritis', 'osteoarthrosis', 'degenerative arthritis', 'glucosamine', 'chondroitin' and 'glycosaminoglycans'. Additional studies were located through searching the citation lists of review articles and published (...) Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis McAlindon T E, LaValley M P, Gulin J P, Felson D T. Authors' objectives To evaluate the benefit of glucosamine and chondroitin preparations for osteoarthritis (OA

2000 DARE.

591. A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis

800 to 2000mg daily was compared to placebo. Concomitant treatment with analgesics and non steroidal anti-inflammatory drugs (NSAIDs) was allowed. Participants included in the review Patients with osteoarthritis of the hip and knee joints were included. Outcomes assessed in the review The following outcomes were assessed: pain visual analogue score; Lequense Index; patient's and physician's global assessment; NSAID consumption; and side effects. How were decisions on the relevance of primary (...) be useful in osteoarthritis, but further investigation in larger cohorts of patients for longer time periods are needed to prove its usefulness as a symptom modifying drug in OA. CRD commentary The aims were stated and inclusion criteria defined in terms of study design, outcomes, intervention and participants, though it was not clear which criteria were used to diagnose patients with OA. Two databases were searched, but no mention was made of any limitations applied in respect of dates or languages

2000 DARE.

592. Cost-effectiveness of aerobic and resistance exercise in seniors with knee osteoarthritis

, Shumaker S. The evaluation of pain in patients with knee osteoarthritis: the knee pain scale. Journal of Rheumatology 1995;22:1124-9. Indexing Status Subject indexing assigned by NLM MeSH Aged; Community Health Services /economics; Cost-Benefit Analysis; Disabled Persons; Exercise Therapy /economics; Female; Geriatrics; Humans; Knee Joint /pathology; Male; Middle Aged; Osteoarthritis /economics /pathology /rehabilitation; Patient Education as Topic; Weight Lifting AccessionNumber 22000007671 Date (...) Cost-effectiveness of aerobic and resistance exercise in seniors with knee osteoarthritis Cost-effectiveness of aerobic and resistance exercise in seniors with knee osteoarthritis Cost-effectiveness of aerobic and resistance exercise in seniors with knee osteoarthritis Sevick M A, Bradham D D, Muender M, Chen G J, Enarson C, Dailey M, Ettinger W H Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief

2000 NHS Economic Evaluation Database.

593. Electrical muscle stimulation for osteoarthritis of the knee: biological basis and systematic review

status of people with knee osteoarthritis (OA). Searching The following sources were searched for articles published in the English language: MEDLINE from 1966 to 1999, CINAHL from 1982 to 1999, and EMBASE from 1980 to 1999. The keywords were 'electrical stimulation', 'electrostimulation therapy', 'osteoarthritis', 'knee', 'physiotherapy', 'randomised clinical trials', 'randomised controlled trials' and 'muscle'. In addition, the Cochrane Database of Systematic Reviews was searched from 1991 to 1999 (...) parameters. Participants included in the review Patients with OA of the knee were eligible. The included participants were those with OA, severe OA, total knee arthroplasty, and those awaiting knee surgery. The majority of trials only included individuals with severe OA. The documented age ranged from 53 to 86 years; the mean age was 68.4 years. Details of disease severity and disability, gender, co-morbid conditions, disease duration and weight were either unclear or were not generally documented

2000 DARE.

594. Acupuncture for chronic osteoarthritis pain, headache and low back pain

Subject indexing assigned by CRD MeSH Acupuncture Therapy; Chronic Disease; Complementary Therapies; Headache; Low Back Pain; Osteoarthritis; Pain Language Published English Country of organisation United States Address for correspondence 8009 34th Avenue South, Suite 1200, Bloomington, MN, USA. Tel: +1 952 814 7060; Fax: +1 952 858 9675 Email: icsi.info@icsi.org AccessionNumber 32003000534 Date bibliographic record published 14/07/2003 Date abstract record published 14/07/2003 Health Technology (...) Acupuncture for chronic osteoarthritis pain, headache and low back pain Acupuncture for chronic osteoarthritis pain, headache and low back pain Acupuncture for chronic osteoarthritis pain, headache and low back pain Institute for Clinical Systems Improvement Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Institute for Clinical Systems Improvement. Acupuncture

2000 Health Technology Assessment (HTA) Database.

595. Shoulder arthroplasty with or without resurfacing of the glenoid in patients who have osteoarthritis

of Bone and Joint Surgery. American volume 2000; 82A(1): 26-34 Indexing Status Subject indexing assigned by NLM MeSH Aged; Arthroplasty, Replacement /economics /methods; Costs and Cost Analysis; Female; Hospital Charges; Humans; Male; Middle Aged; Osteoarthritis /diagnosis /radiography /surgery; Postoperative Complications; Range of Motion, Articular; Research Support, Non-U.S. Gov't; Shoulder Joint /physiopathology /radiography /surgery AccessionNumber 22000000195 Date bibliographic record published (...) Shoulder arthroplasty with or without resurfacing of the glenoid in patients who have osteoarthritis Shoulder arthroplasty with or without resurfacing of the glenoid in patients who have osteoarthritis Shoulder arthroplasty with or without resurfacing of the glenoid in patients who have osteoarthritis Gartsman G M, Roddey T S, Hammerman S M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary

2000 NHS Economic Evaluation Database.

596. Use of the ACCES model to predict the health economic impact of celecoxib in patients with osteoarthritis or rheumatoid arthritis in Norway

evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The use of celecoxib for the treatment of patients with osteoarthritis (OA) or rheumatoid arthritis (RA), in Norway. Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population The study population consisted (...) health care at reduced cost for patients with OA and RA. Generalisability to other economic settings will depend on their similarity to Norway. Source of funding None stated. Bibliographic details Svarvar P, Aly A. Use of the ACCES model to predict the health economic impact of celecoxib in patients with osteoarthritis or rheumatoid arthritis in Norway. Rheumatology 2000; 39(Supplement 2): 43-50 PubMedID Other publications of related interest 1. Pettitt D, Goldstein JL, McGuire A, Schwartz S, Burke T

2000 NHS Economic Evaluation Database.

597. Osteoarthritis treatment with Hyalgan - an HTA

Osteoarthritis treatment with Hyalgan - an HTA Osteoarthritis treatment with Hyalgan - an HTA Osteoarthritis treatment with Hyalgan - an HTA Maschoreck T Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Maschoreck T. Osteoarthritis treatment with Hyalgan - an HTA. Copenhagen: Danish Centre for Evaluation and Health Technology Assessment (...) (DACEHTA). 2000 Authors' objectives This report aims to assess whether Hyalgan is an adequate treatment offer for patients with osteoarthritis. Authors' conclusions If the treatment is introduced it should be applied for patients who have been slightly or moderately affected, while more serious cases should be offered alloplastics. Introduction of the treatment in hospitals would imply - besides an investment of 900,000 DKK for drug expenses - half a permanent post for a nurse and half a permanent post

2000 Health Technology Assessment (HTA) Database.

598. Clinical efficacy of low power laser therapy in osteoarthritis

: osteoarthritis, articular cartilage, arthritis, joints, lasers, laser therapy, low level laser therapy, infra-red rays, phototherapy, and therapeutic intervention. Other databases investigated included Exerpta Medica, Science Citation Index, MEDLARS, Index Medicus, and Health. Study selection Study designs of evaluations included in the review Only controlled, blinded clinical studies were considered for inclusion in the review. Specific interventions included in the review Infra-red laser therapy and helium (...) Clinical efficacy of low power laser therapy in osteoarthritis Clinical efficacy of low power laser therapy in osteoarthritis Clinical efficacy of low power laser therapy in osteoarthritis Marks R, de Palma F Authors' objectives To conduct a systematic and critical analysis of studies of patient outcomes following either continuous or pulsed low level laser treatment of an osteoarthritic joint. Searching MEDLINE (1966 to 1998), CINAHL (1982 to 1998) were searched using the following terms

1999 DARE.

599. Economic evaluation of a primary care-based education programme for patients with osteoarthritis of the knee

the intervention in the Osteoarthritis of the Knee (OAK) study 3. To estimate the impact of the programme on the direct and indirect costs of health care related to knee arthritis over the year of follow-up. Authors' conclusions The OAK study failed to demonstrate improvements in knowledge, self-efficacy in arthritis management, or health outcomes after one year. The evidence in this study lends support to the contention that general practice based patient education programmes for knee osteoarthritis (...) Economic evaluation of a primary care-based education programme for patients with osteoarthritis of the knee Economic evaluation of a primary care-based education programme for patients with osteoarthritis of the knee Economic evaluation of a primary care-based education programme for patients with osteoarthritis of the knee Lord J, Victor C, Littlejohns P, Ross F M, Axford J S Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA

1999 Health Technology Assessment (HTA) Database.

600. Economic evaluation of a primary care-based education programme for patients with osteoarthritis of the knee Full Text available with Trip Pro

Economic evaluation of a primary care-based education programme for patients with osteoarthritis of the knee Economic evaluation of a primary care-based education programme for patients with osteoarthritis of the knee: a review Journals Library An error has occurred in processing the XML document An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from

1999 NIHR HTA programme